Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Accenture Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value remained flat by 0.0% to $77.59 in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $73.17 to $77.59. Over 4 years (FY 2021 to FY 2025), Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value shows an upward trend with a 18.0% CAGR.
Analysis
How to read this metric
Higher values reflect awards granted when the company's stock price was higher, potentially impacting future compensation expense projections.
Detailed definition
The average grant-date fair value per share for equity instruments that vested during the period. This metric provides i...
Peer comparison
Standard disclosure for companies utilizing equity-based compensation plans.
other_share_based_compensation_arrangement_by_share_base_a5406bHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $160.05 | $200.46 | $248.06 | $292.66 | $310.36 |
| YoY Change | — | +25.2% | +23.7% | +18.0% | +6.0% |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value at Other Companies
Frequently Asked Questions
- What is Accenture's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value?
- Accenture (ACN) reported share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value of $77.59 in Q2 2025.
- How has Accenture's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value changed year-over-year?
- Accenture's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value increased by 6.0% year-over-year, from $73.17 to $77.59.
- What is the long-term trend for Accenture's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value?
- Over 4 years (2021 to 2025), Accenture's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value has grown at a 18.0% compound annual growth rate (CAGR), from $160.05 to $310.36.
- What does share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value mean?
- The average value per share at the time of grant for awards that vested this period.